Richa Mukerjee and colleagues’ new paper, “ENDS, cigarettes, and respiratory illness: Longitudinal associations among US youth,” adds strong evidence to the conclusion that e-cigarettes cause lung disease (bronchitis, pneumonia, or chronic cough) among young people (age 12-17). They used 6 years of longitudinal data (where you follow the same people forward in time) to measureContinue reading “More evidence that ecigs cause lung disease in youth like cigs; dual use is worse”
Category Archives: lung disease
New strong evidence that Juul is more toxic to lungs and hearts than earlier e-cigs
Two new papers strongly suggest that Juul (and, likely, other fourth generation e-cigarettes) are more dangerous than earlier tank systems. One, Differential Toxicity of Electronic Cigarette Aerosols Generated from Different Generations of Devices In Vitro and In Vivo, finds that Juul has higher pulmonary toxicity than earlier tank systems and the second, Nicotine Formulation InfluencesContinue reading “New strong evidence that Juul is more toxic to lungs and hearts than earlier e-cigs”
First longitudinal evidence linking e-cig use and death
Shauna Goldberg Scott and her colleagues recently published the first longitudinal evidence (where people are followed forward in time, the strongest kind of epidemiological study) showing that e-cigarette use was associated with increased risk of death. Their paper, Demographic, Clinical, and Behavioral Factors Associated With Electronic Nicotine Delivery Systems Use in a Large Cohort inContinue reading “First longitudinal evidence linking e-cig use and death”
Improving EPA’s cumulative risk assessment procedures
In response to President Biden’s 2021 Executive Orders to advance racial equity, increase resources for underserved communities, and address the climate crisis, the Environmental Protection Agency has developed and released “Draft Proposed Principles of Cumulative Risk Assessment under the Toxic Substances Control Act.” While the draft includes many good points, in some ways it willContinue reading “Improving EPA’s cumulative risk assessment procedures”
UC publishes oral history of Stanton Glantz: Putting Cardiovascular, Epidemiological, Economic, Political, and Policy Research into Action at UC San Francisco and Beyond
Today the Oral History Center at the University of California Bancroft Library published an oral history of my career, which is freely available to all. Beginning in elementary school in Cleveland, Ohio, the history follows me through college and gradual school. It discusses my work to develop the emergency protocols for the Apollo 5 missionContinue reading “UC publishes oral history of Stanton Glantz: Putting Cardiovascular, Epidemiological, Economic, Political, and Policy Research into Action at UC San Francisco and Beyond”
Watch “E-cigarettes: Harm enhancement and protection of global tobacco interests”
On May 31, 2023, I delivered an invited lecture to the Associação Brasileira de Estudos do Álcool e outras Drogas (Brazilian Association for the Study of Alcohol and Other Drugs) entitled “E-cigarettes: Harm enhancement and protection of global tobacco interests.” As the title indicates it is a comprehensive review of the current state of knowledgeContinue reading “Watch “E-cigarettes: Harm enhancement and protection of global tobacco interests””
Switching from cigarettes to e-cigarettes does not reduce respiratory symptoms
Jonathan Berlowitz and colleagues’ new paper Cigarette‒E-cigarette Transitions and Respiratory Symptom Development adds to the already strong case that e-cigarette use increases the risk of respiratory symptoms and that dual use (using e-cigarettes while smoking cigarettes) is more dangerous than using either product alone. Most important, switching from cigarettes only to e-cigarettes only did notContinue reading “Switching from cigarettes to e-cigarettes does not reduce respiratory symptoms”
Even a little smoking is bad: Implications for harm reduction
I just came on two important papers — Association of Long-term, Low-Intensity Smoking With All-Cause and Cause-Specific Mortality in the National Institutes of Health-AARP Diet and Health Study and Association between long-term low-intensity cigarette smoking and incidence of smoking-related cancer in the National Institutes of Health-AARP cohort by Maki Inoue Choi and her colleagues atContinue reading “Even a little smoking is bad: Implications for harm reduction”
Compromised blood vessel function caused by cigarettes and e-cigarettes is mediated by lung irritation
Cigarettes and e-cigarettes deliver the addictive drug nicotine to the lungs where it is absorbed and rapidly delivered to the brain. The holy grail of the idea that e-cigarettes are a form of harm reduction is that the e-cigarette aerosol has fewer specific bad chemicals than cigarette smoke. New research from Pooneh Nabavizadeh and colleaguesContinue reading “Compromised blood vessel function caused by cigarettes and e-cigarettes is mediated by lung irritation”
FDA proposed updating its HPHC list in 2019; it needs to finish the job
One of the nerdy, but very important, parts of the FDA tobacco product regulatory process is the list of “Hazardous and Potentially Hazardous Compounds” (HPHC) list that FDA released in 2012. This list contains 93 bad chemicals — mostly carcinogens — that FDA identified as important when assessing the risks of tobacco products. It hasContinue reading “FDA proposed updating its HPHC list in 2019; it needs to finish the job”
Stanton Glantz blog 